Ro, a telehealth company, has teamed up with Eli Lilly to improve patient access to Zepbound (tirzepatide). Through ...

Novo Nordisk’s blockbuster drug Ozempic got another star added to its label Thursday, in an encouraging sign for the ...

周五，伯恩斯坦分析师强调了GLP-1药物在应对全球肥胖流行中的重要作用，特别强调了诺和诺德公司的Wegovy和礼来的Zepbound目前在市场上的主导地位。礼来市值超过7050亿美元，过去12个月收入增长27%，是这个不断扩大的市场中的重要参与者。

Stock Editorial via Getty Images An expert panel of the EU drug regulator, the European Medicines Agency (EMA), has ...

Eli Lilly, the pharma giant behind the popular weight-loss drug Zepbound, said it plans to test obesity medications as a ...